Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

9th Feb 2011 11:15

RNS Number : 9398A
Consort Medical PLC
09 February 2011
 



 

 

 

News Release

 

9 February 2011

 

 

Consort Medical plc

 

Consort Medical announces the appointment of Dr. Lynn Drummond to the Board

 

Consort Medical plc ("Consort") is pleased to announce the appointment of Dr. Lynn Drummond as a Board member, effective today.

 

Dr. Drummond has a strong track record within the life sciences sector, bringing over twenty years of management and advisory experience. Lynn spent 16 years at Rothschild in London most recently as a Managing Director within the investment banking division, with a particular focus on transactions within the healthcare sector. Prior to this she worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. Lynn is also a non executive director of Alimentary Health in Ireland.

 

Dr. Drummond holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is also a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

 

Commenting on Dr. Drummond's appointment, Peter Fellner, Chairman said:

"We are delighted that Lynn is joining Consort as a Board member. Lynn brings a tremendous set of skills and experience to the Board and we look forward to working with her."

 

Dr. Lynn Drummond commented:

"Consort has an established reputation as a leader in pharmaceutical drug delivery systems and I look forward to being a part of this growing business and working with the Board to deliver value for shareholders."

 

 

END

 

Enquiries

Consort Medical plc

Tel: +44 (0) 1442 867920

Jonathan Glenn, Chief Executive Officer

Toby Woolrych, Group Finance Director

Brunswick

Tel: +44 (0) 20 7404 5959

Jon Coles/Justine McIlroy

 

Consort Medical plc is a leader in medical devices for drug delivery and device technologies. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.

 

Consort Medical develops and manufactures metered dose inhaler valves, autoinjectors, needle free injectors, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits, video laryngoscopes and laryngeal tubes. The Group has a Head Office in Hemel Hempstead, UK and manufacturing facilities in King's Lynn, Norfolk, and Nelson, Lancashire in the UK, Indianapolis, Indiana and Kent, Ohio in the US. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGGZMLDGMZM

Related Shares:

CSRT.L
FTSE 100 Latest
Value8,842.25
Change32.51